Is Ginkgo Cognitive Performance Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Ginkgo Cognitive Performance Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - After 12 months,therapy was associated with reduced amyloid ß-protein oligomerisation a well as preserved cognition and improved daily functioning (). [Feng Jing-Xuan (2026); evidence level 1] - However, their clinical significance remains uncertain, and certainty of evidence is overall low due to significant heterogeneity (). [Feng Jing-Xuan (2026); evidence level 1] - A controlled clinical study conducted in China demonstrated that EGb 761 as an add-on to standard treatment improved cognition and general health in patients who had had an ischaemic stroke (). [Feng Jing-Xuan (2026); evidence level 1] - 1 1 2 While the global incidence of stroke is in decline in most regions, it is rising in China. [Feng Jing-Xuan (2026); evidence level 1] - Conclusion The NMA results indicate that in terms of learning and memory functions, raisin and tart cherry ranked higher; in terms of executive functions, the bacopa monnieri compound demonstrated a relatively better intervention effect, providing an important basis for non-drug interventions for cognitive health in the healthy older adults. [Feng X (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.